URGENT RECALL: BRAVELLE® FOLLICLE-STIMULATING HORMONE RECALLED FOR LACK OF EFFICACY In October of 2015, Ferring Pharmaceuticals quietly initiated a voluntary, class 2 recall of Bravelle® (75 IU dose, injection-method, NDC…

Read more